Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
HIV Medicine|October 11, 2021
No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adultsJames E Burns, Oliver Stirrup, Laura Waters, et al.
AIDS (London, England)|March 24, 2012
Discontinuation of Atripla as first-line therapy in HIV-1 infected individualsAndrew Scourfield, Jiexin Zheng, Suchitra Chinthapalli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
The risks and incidence of K65R and L74V mutations and subsequent virologic responsesLaura Waters, Mark Nelson, Sundhiya Mandalia, et al.
Infectious Diseases (London, England)|March 29, 2022
Prolonged SARS-CoV-2 shedding in a person living with advanced HIV and diffuse large B-cell lymphoma: a case reportIrfaan Maan, Stavroula Maria Paraskevopoulou, Kate Cwynarski, et al.
International Journal of Cancer|March 10, 2005
Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort studyLaura Waters, Justin Stebbing, Sundhiya Mandalia, et al.
HIV Medicine|March 28, 2022
Covid-19 First Wave Impact National Survey for HIV Clinicians by Public Health England (PHE), the British HIV Association (BHIVA) and the Children's HIV Association (CHIVA)Gabriella Shanks, Ammi Shah, Amanda Williams, et al.
International Journal of STD & AIDS|July 4, 2017
What impact has tendering had on trainees? Results of a national survey by British Association for Sexual Health and HIV Trainees' Collaborative for audit, research and quality improvement projectsHelen Wiggins, Anna Hartley, Emily Clarke, et al.
Current Drug Delivery|April 2, 2021
Magnesium Aluminium Silicate-Metformin Hydrochloride Complexes - The Use of Isothermal Calorimetry for Probing Clay and Drug NanocomplexationsAna-Maria Totea, Irina Dorin, Peter R Laity, et al.
The Journal of Antimicrobial Chemotherapy|March 31, 2009
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteersLaura Dickinson, Marta Boffito, David Back, et al.
Antiviral Therapy|May 9, 2013
Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backboneLaura Waters, Loveleen Bansi, David Asboe, et al.
Pageof 11